These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 38548788)

  • 21. Levodopa-Induced Dyskinesia in Parkinson's Disease: Pathogenesis and Emerging Treatment Strategies.
    Kwon DK; Kwatra M; Wang J; Ko HS
    Cells; 2022 Nov; 11(23):. PubMed ID: 36496996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered dynamic functional network connectivity in levodopa-induced dyskinesia of Parkinson's disease.
    Si Q; Gan C; Zhang H; Cao X; Sun H; Wang M; Wang L; Yuan Y; Zhang K
    CNS Neurosci Ther; 2023 Jan; 29(1):192-201. PubMed ID: 36229900
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Tianqi antitremor granules on behavioral manifestations and expression of G protein-coupled receptor kinase 6 and β-arrestin1 in levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Wu N; Yang X; Song L; Wei J; Liu Z
    Drug Des Devel Ther; 2013; 7():1481-9. PubMed ID: 24376341
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Striatal Nurr1 Facilitates the Dyskinetic State and Exacerbates Levodopa-Induced Dyskinesia in a Rat Model of Parkinson's Disease.
    Sellnow RC; Steece-Collier K; Altwal F; Sandoval IM; Kordower JH; Collier TJ; Sortwell CE; West AR; Manfredsson FP
    J Neurosci; 2020 Apr; 40(18):3675-3691. PubMed ID: 32238479
    [TBL] [Abstract][Full Text] [Related]  

  • 25. White matter alterations in Parkinson's disease with levodopa-induced dyskinesia.
    Ogawa T; Hatano T; Kamagata K; Andica C; Takeshige-Amano H; Uchida W; Saito Y; Shimo Y; Oyama G; Umemura A; Iwamuro H; Ito M; Hori M; Aoki S; Hattori N
    Parkinsonism Relat Disord; 2021 Sep; 90():8-14. PubMed ID: 34325387
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pallidal Structural Changes Related to Levodopa-induced Dyskinesia in Parkinson's Disease.
    Youn J; Kim M; Park S; Kim JS; Park H; Cho JW
    Front Aging Neurosci; 2022; 14():781883. PubMed ID: 35601615
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranitidine reduced levodopa-induced dyskinesia in a rat model of Parkinson's disease.
    Cui G; Yang X; Wang X; Zhang Z; Yue X; Shi H; Shen X
    Neuropsychiatr Dis Treat; 2014; 10():39-46. PubMed ID: 24379672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Paradoxical facilitation after depotentiation protocol can precede dyskinesia onset in early Parkinson's disease.
    Lago-Rodriguez A; Ponzo V; Jenkinson N; Benitez-Rivero S; Del-Olmo MF; Hu M; Koch G; Cheeran B
    Exp Brain Res; 2016 Dec; 234(12):3659-3667. PubMed ID: 27566172
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impulse control behaviors and apathy commonly co-occur in de novo Parkinson's disease and predict the incidence of levodopa-induced dyskinesia.
    Zhang Y; Zhu XB; Gan J; Song L; Qi C; Wu N; Wan Y; Hou M; Liu Z
    J Affect Disord; 2024 Apr; 351():895-903. PubMed ID: 38342317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transcriptome Sequencing Reveal That Rno-Rsf1_0012 Participates in Levodopa-Induced Dyskinesia in Parkinson's Disease Rats via Binding to Rno-mir-298-5p.
    Han CL; Wang Q; Liu C; Li ZB; Du TT; Sui YP; Zhang X; Zhang JG; Xiao YL; Cai GE; Meng FG
    Brain Sci; 2022 Sep; 12(9):. PubMed ID: 36138942
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Serial I-123-FP-CIT SPECT Image Findings of Parkinson's Disease Patients With Levodopa-Induced Dyskinesia.
    Jeong EH; Sunwoo MK; Song YS
    Front Neurol; 2018; 9():1133. PubMed ID: 30619078
    [No Abstract]   [Full Text] [Related]  

  • 32. Association of dopamine receptor D3 polymorphism with Levodopa-induced Dyskinesia: A study on Parkinson's disease patients from India.
    Sarkar S; Biswas A; Ansari S; Choudhury S; Banerjee R; Chatterjee S; Dey S; Kumar H
    Neurosci Lett; 2024 Mar; 825():137706. PubMed ID: 38431040
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fyn knockdown prevents levodopa-induced dyskinesia in a mouse model of Parkinson's disease.
    Bordone MP; Damianich A; Bernardi MA; Eidelman T; Sanz-Blasco S; Gershanik OS; Avale ME; Ferrario JE
    eNeuro; 2021 Jun; 8(4):. PubMed ID: 34099487
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Does the Side Onset of Parkinson's Disease Influence the Time to Develop Levodopa-Induced Dyskinesia?
    Chung SJ; Yoo HS; Lee HS; Lee PH; Sohn YH
    J Parkinsons Dis; 2019; 9(1):241-247. PubMed ID: 30741690
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Associations between variants in levodopa metabolic pathway genes and levodopa-induced dyskinesia in Parkinson's disease.
    Yan JH; Ge YL; Wang PZ; Li W; Jin H; Zhang JR; Chen J; Wang F; Li D; Mao CJ; Li K; Liu CF
    Neurosci Lett; 2023 Mar; 801():137140. PubMed ID: 36813078
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological Correlates of Neuroanatomical Changes in a Rat Model of Levodopa-Induced Dyskinesia Based on Voxel-Based Morphometry.
    Zhang X; Chen W; Wu Y; Zeng W; Yuan Y; Cheng C; Yang X; Wang J; Yang X; Xu Y; Lei H; Cao X; Xu Y
    Front Aging Neurosci; 2021; 13():759934. PubMed ID: 34776935
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Presynaptic dopamine depletion determines the timing of levodopa-induced dyskinesia onset in Parkinson's disease.
    Yoo HS; Chung SJ; Chung SJ; Moon H; Oh JS; Kim JS; Hong JY; Ye BS; Sohn YH; Lee PH
    Eur J Nucl Med Mol Imaging; 2018 Mar; 45(3):423-431. PubMed ID: 29075830
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Metabolic Profile in Plasma AND CSF of LEVODOPA-induced Dyskinesia in Parkinson's Disease: Focus on Neuroinflammation.
    Santos-Lobato BL; Gardinassi LG; Bortolanza M; Peti APF; Pimentel ÂV; Faccioli LH; Del-Bel EA; Tumas V
    Mol Neurobiol; 2022 Feb; 59(2):1140-1150. PubMed ID: 34855116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Small and Large Magnetic Resonance Imaging-Visible Perivascular Spaces in the Basal Ganglia of Parkinson's Disease Patients.
    Ramirez J; Berberian SA; Breen DP; Gao F; Ozzoude M; Adamo S; Scott CJM; Berezuk C; Yhap V; Mestre TA; Marras C; Tartaglia MC; Grimes D; Jog M; Kwan D; Tan B; Binns MA; Arnott SR; Bartha R; Symons S; Masellis M; Black SE; Lang AE;
    Mov Disord; 2022 Jun; 37(6):1304-1309. PubMed ID: 35403259
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Striatal D
    Gao S; Gao R; Yao L; Feng J; Liu W; Zhou Y; Zhang Q; Wang Y; Liu J
    Front Aging Neurosci; 2022; 14():783893. PubMed ID: 35185524
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.